Meta-Analysis
Writing Help
Quantitative research synthesis sits at the apex of the evidence hierarchy — and demands expertise across three disciplines simultaneously: information science, research methodology, and biostatistics. PRISMA 2020, forest plots, heterogeneity, risk of bias, GRADE. We produce every component to publication standard.
What Is a Meta-Analysis — and Why Is It the Hardest Paper You Will Ever Write?
A meta-analysis is a quantitative research synthesis methodology that statistically combines the results of multiple independent studies addressing the same research question. By pooling data across studies — each carrying its own random sampling error — a meta-analysis increases statistical power dramatically and produces an effect estimate with a narrower confidence interval than any individual study alone can provide. The result is a more reliable, generalisable answer to a research question than any single study is capable of delivering.
The term was formally coined by psychologist Gene V. Glass in his 1976 Presidential Address to the American Educational Research Association, where he described it as “the statistical analysis of a large collection of analysis results from individual studies for the purpose of integrating the findings.” In the decades since, meta-analysis has become the dominant form of evidence synthesis across health sciences, psychology, education, economics, and management research — and has been systematised into a rigorous methodology governed by internationally accepted reporting standards, primarily the PRISMA 2020 statement.
The challenge for graduate students and doctoral candidates is that conducting a meta-analysis properly demands competence in at least three distinct disciplines simultaneously. Information science is required for the database search strategy — developing MeSH terms, constructing Boolean search strings across multiple databases (MEDLINE, Embase, PsycINFO, CINAHL, CENTRAL), and systematically capturing grey literature to guard against publication bias. Research methodology is required for eligibility assessment, data extraction, and risk of bias appraisal using validated tools (RoB 2, ROBINS-I, QUADAS-2). And biostatistics is required for effect size calculation, model selection between fixed and random effects approaches, heterogeneity quantification (I², Q, τ²), subgroup and sensitivity analyses, and publication bias testing (Egger’s test, funnel plot, trim-and-fill). Few doctoral programmes train students in all three simultaneously.
The distinction between a systematic review and a meta-analysis is one of the most frequently confused points in graduate research writing. A systematic review is a rigorous, reproducible literature synthesis — it may synthesise evidence narratively or quantitatively. A meta-analysis is the quantitative synthesis step: the statistical pooling of effect estimates across studies. All meta-analyses are systematic reviews; not all systematic reviews include a meta-analysis. Statistical pooling is only appropriate when included studies are sufficiently similar in design, population, intervention, and outcome measurement. When pooling is inappropriate, the review synthesises evidence narratively — this is still a valid systematic review, but it does not include a meta-analysis. Using the terms interchangeably in a manuscript is a signal of methodological unfamiliarity that peer reviewers and dissertation committees will notice immediately.
PROSPERO registration: The International Prospective Register of Systematic Reviews (hosted at the University of York) allows prospective registration of your protocol before searching begins. Most journals require a PROSPERO registration number. It provides a date-stamped record of your pre-specified methods and protects against accusations of outcome-reporting bias. We assist with protocol development and PROSPERO registration documentation as a standard service component.
“The statistical analysis of a large collection of analysis results from individual studies for the purpose of integrating the findings.”Gene V. Glass, 1976 — The definition that named the method
The Evidence Hierarchy and the Position of Meta-Analysis
Evidence pyramid in biomedical and social sciences.
Meta-analyses of RCTs occupy the apex when conducted to Cochrane standards.
The evidence hierarchy — sometimes called the evidence pyramid — ranks study designs according to the degree of protection they provide against systematic bias. Meta-analyses occupy the apex for a fundamental statistical reason: precision through aggregation. Any individual study’s effect estimate is subject to random sampling variation. When you pool data from multiple studies, the combined sample size increases, the standard error of the pooled estimate shrinks, and the confidence interval narrows — delivering a more precise estimate of the true population effect. This is a direct consequence of the mathematics of variance reduction.
The limitation of the pyramid is encapsulated in the phrase garbage in, garbage out. A meta-analysis pools the biases of its included studies as readily as it pools their evidence. If the included studies systematically overestimate treatment effects — due to inadequate blinding, selective outcome reporting, or small-study effects — the pooled estimate will also be biased, and with misleadingly narrow confidence intervals. This is precisely why risk of bias assessment, sensitivity analysis, and publication bias testing are not optional additions to a meta-analysis. They are fundamental quality controls without which the pooled estimate is scientifically uninterpretable.
The GRADE framework (Grading of Recommendations Assessment, Development and Evaluation) provides the standard method for translating meta-analytic findings into a certainty-of-evidence judgment. Evidence from meta-analyses of RCTs begins as high certainty and may be downgraded to moderate, low, or very low based on five domains: risk of bias in included studies, inconsistency (unexplained heterogeneity), indirectness (mismatch between PICO elements of the evidence and the review question), imprecision (wide confidence intervals), and publication bias. Evidence from observational study meta-analyses begins as low certainty but may be upgraded for large effect size, dose-response, or absence of plausible confounders. The Cochrane Collaboration, the global network that has systematised review and meta-analysis methodology most rigorously, requires GRADE Summary of Findings tables in all Cochrane Reviews. We produce GRADE SoF tables using GRADEpro GDT as a standard deliverable for full meta-analysis orders.
Understanding where meta-analysis sits in the hierarchy also matters for your dissertation committee, your target journal, and the practical significance of your findings. A PhD thesis whose primary contribution is a well-conducted, PROSPERO-registered, PRISMA 2020-compliant meta-analysis carries genuine scholarly weight — it is not merely a literature summary. Our dissertation writing service handles meta-analysis components as a specialised offering within doctoral research support.
What Makes a Meta-Analysis Fail Peer Review
The most common reasons meta-analysis manuscripts are rejected by peer reviewers are: (1) no PROSPERO registration or absence of a pre-specified protocol, indicating possible outcome-switching; (2) inadequate search strategy — single database, missing MeSH terms, no grey literature; (3) incorrect or absent risk of bias assessment, or use of the wrong tool for the study designs included; (4) failure to address heterogeneity when I² is high; (5) no publication bias assessment; (6) pooling of studies that are too clinically or methodologically heterogeneous to combine; and (7) PRISMA non-compliance. All of these are methodological failures, not writing failures — which is why meta-analysis writing support requires statistical expertise, not just academic writing skill. Our statistics and data analysis service addresses all quantitative components of meta-analysis methodology.
The PICO Framework — Formulating Your Research Question
Every meta-analysis begins with a precisely formulated research question. Vague questions produce meta-analyses with inappropriate inclusion criteria, excessive heterogeneity, and results that cannot be meaningfully interpreted. PICO is the standard framework.
Population — Who are the participants?
The specific patient or participant group, including relevant demographic characteristics, clinical diagnoses, comorbidities, and settings. Precision matters: “adults” is too broad; “adults aged 18–65 with a confirmed diagnosis of type 2 diabetes mellitus in outpatient primary care settings in high-income countries” is appropriately specified. The population element determines the clinical or practical applicability of your pooled findings and defines what counts as an eligible study. Subgroup analyses for population-level moderators (age group, sex, severity of condition) should be pre-specified here.
Intervention — What is being evaluated?
The specific intervention, exposure, prognostic factor, diagnostic test, or policy under investigation — specified with sufficient precision to distinguish it from related but distinct interventions. “Exercise” is too broad; “supervised aerobic exercise training, ≥3 sessions per week, ≥8 weeks duration, in a clinical or community setting” is appropriately specific. For pharmacological interventions, specify drug class, dose range, and administration route. For complex interventions, describe the active components. The level of specificity here directly shapes the clinical or methodological heterogeneity of your included study set.
Comparison — What is the comparator?
The comparator against which the intervention is assessed: active control, placebo, usual care, waitlist, no intervention, or another intervention. For some review questions, a comparator may not be required (prevalence meta-analyses, diagnostic accuracy reviews). When multiple comparators are included, a network meta-analysis framework may be required to produce indirect comparisons between interventions not directly compared in any individual study. Specifying the comparator precisely is essential for correctly applying eligibility criteria at the full-text screening stage — a missing comparator definition is a frequent source of inter-rater disagreement in the screening process.
Outcome — What will be measured?
The primary and secondary outcomes of interest, specified with sufficient precision to guide data extraction — including the measurement instrument or scale (BDI-II, PHQ-9, HbA1c, 6-minute walk test), the time point of measurement (post-treatment, 6 months, 12 months), and the direction of the expected effect. Outcomes should be hierarchically ordered: primary (the main basis for the pooled estimate), secondary (supporting outcomes), and adverse effects. Surrogate endpoints should be clearly distinguished from clinically meaningful outcomes. If all included studies use the same measurement instrument, a raw mean difference (RMD) can be used; if instruments differ, the standardised mean difference (SMD: Cohen’s d or Hedges’ g) is required.
Alternative frameworks: PICOS adds S for Study design (restricts inclusion to specific designs, e.g. RCTs only). PICOT adds T for Timeframe. PEO (Population, Exposure, Outcome) is used for observational aetiology questions where there is no intervention. SPIDER (Sample, Phenomenon of Interest, Design, Evaluation, Research type) is used for qualitative evidence synthesis. The framework selected must be specified in the PROSPERO protocol before searching begins. We assist with framework selection and protocol development for all meta-analysis orders. See our research paper writing service.
PRISMA 2020 — The Reporting Standard Every Journal Requires
The PRISMA 2020 statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyses), available at prisma-statement.org, is the current reporting guideline for systematic reviews and meta-analyses. Published in 2021 across multiple high-impact journals including BMJ, PLOS Medicine, and the Journal of Clinical Epidemiology, the updated 2020 version reflects methodological advances since the 2009 original — including updated guidance on searching grey literature, registering protocols, assessing certainty of evidence using GRADE, and reporting search strategies in machine-readable format. Most peer-reviewed journals in health sciences, psychology, education, and social sciences now require PRISMA compliance as a condition of submission.
The title must explicitly identify the paper as a systematic review, a meta-analysis, or both. The abstract must be structured: background, objectives, data sources, eligibility criteria, results (number of studies, participants, and pooled effect with 95% CI), and conclusions. The PROSPERO registration number must appear in both the abstract and the methods section. PRISMA 2020 also requires disclosure of any deviations from the registered protocol, with explanations.
The introduction must establish why the review is needed (the gap in current knowledge), what the existing evidence base looks like (prior reviews and their limitations), and precisely what question the current review addresses. The objectives section must state the PICO research question explicitly — not a vague aim, but a precisely formulated question specifying population, intervention, comparator, and outcome. Journals will reject manuscripts whose objectives section does not map directly to the eligibility criteria and outcome data extracted.
Eligibility criteria must specify all PICO elements, eligible study designs, language restrictions (with justification), and date restrictions (with justification). The search strategy section must document every database searched, the date of search, the full search string for each database (typically in a supplementary appendix using PRESS format), grey literature sources consulted, and whether reference list and citation searching were performed. PRISMA 2020 explicitly requires that search strategies be reported in sufficient detail for exact replication by another researcher — a requirement many manuscripts fail to meet. Two-reviewer independent screening must be described, including the method for resolving disagreements.
Data extraction must be described: the variables extracted, the form used (pilot-tested or not), and the number of independent extractors. The risk of bias assessment tool must be named and referenced — RoB 2 for RCTs, ROBINS-I for non-randomised studies, QUADAS-2 for diagnostic accuracy studies. The level at which risk of bias was assessed (study level vs outcome level) must be specified. PRISMA 2020 requires that risk of bias assessment be performed by two independent reviewers, with a named method for disagreement resolution.
The statistical methods section must specify: the effect measure used and its rationale (Cohen’s d, odds ratio, risk ratio, correlation coefficient); the pooling model selected (fixed or random effects) and its justification; the estimator used for τ² (DerSimonian-Laird, REML, Hartung-Knapp); the heterogeneity statistics to be reported (I², Q, τ² with 95% CI); any pre-specified subgroup analyses with their moderator variables and rationale; sensitivity analyses (e.g., excluding high-risk-of-bias studies); and the publication bias assessment method. All subgroup and sensitivity analyses must be pre-specified — post-hoc data-dredging for significant subgroup effects is a serious methodological violation that reviewers are trained to identify.
Results must include the PRISMA flow diagram, characteristics of included studies table, risk of bias summary (traffic light plot for RoB 2), forest plot(s) with pooled estimate and 95% CI, heterogeneity statistics, subgroup and sensitivity analysis results, funnel plot with Egger’s test results (if k ≥ 10), and a GRADE Summary of Findings table. The discussion must interpret findings in the context of existing evidence, address the consistency and applicability of the pooled estimate, explicitly discuss limitations (including risk of bias in the included studies, search limitations, and potential for publication bias), and draw conclusions that do not exceed what the evidence supports. The conclusions section is frequently over-interpreted in manuscript submissions — a finding that is statistically significant is not necessarily clinically meaningful.
Publication-standard components as standard deliverables
PROSPERO Protocol Documentation
Full protocol in PROSPERO-required format, including PICO, eligibility criteria, databases, analysis plan. Registration documentation prepared for submission.
Multi-Database Search Strategy
MEDLINE/PubMed, Embase, PsycINFO, CINAHL, CENTRAL. Full PRESS-format documentation with MeSH terms, free-text synonyms, and Boolean operators. Grey literature coverage.
PRISMA Flow Diagram
Publication-ready PRISMA 2020 flow diagram documenting all records from identification through inclusion. Vector or high-resolution bitmap format.
Risk of Bias Assessment
RoB 2, ROBINS-I, or QUADAS-2 applied correctly to your study designs. Traffic light plot and summary table included.
Forest Plots
Main analysis and subgroup forest plots in publication-ready format. Pooled estimate, 95% CI, study weights, and heterogeneity statistics displayed.
Annotated Analysis Scripts
Fully annotated, reproducible R (metafor) or Stata scripts — every step explained in plain English for supervisor and committee presentation.
GRADE Summary of Findings
Certainty of evidence assessed across five GRADE domains. SoF table produced in GRADEpro GDT format.
The Search Strategy and PRISMA Flow Diagram
Illustrative PRISMA 2020 Flow
Illustrative example only. Actual numbers vary by review topic and databases searched.
The search strategy is the methodological foundation on which the entire meta-analysis rests. A poorly designed search — one that misses relevant databases, neglects MeSH terms, fails to capture grey literature, or cannot be exactly reproduced by another researcher — will produce an included study set that does not represent the full evidence base. This directly compromises the validity of the pooled estimate and is among the most frequent causes of meta-analysis manuscript rejection at peer review.
A PRISMA 2020-compliant search for a health sciences meta-analysis covers at minimum: MEDLINE via PubMed or Ovid (with MeSH headings and explosion, combined with free-text synonyms using Boolean operators); Embase (Emtree thesaurus terms); PsycINFO (APA Thesaurus); CINAHL (CINAHL Subject Headings); and Cochrane CENTRAL. Social science and management meta-analyses add ERIC, Sociological Abstracts, Business Source Complete, or EconLit as appropriate. Search strings are documented in database-specific format in the supplementary appendix using PRESS (Peer Review of Electronic Search Strategies) standards.
Grey literature is searched to guard against publication bias — the selective non-publication of null and negative results. Sources include clinical trial registries (ClinicalTrials.gov, WHO ICTRP, EudraCT), government agency reports, dissertations (ProQuest, EThOS, DART-Europe), and forward citation searching via Web of Science or Google Scholar. Reference lists of included studies are hand-searched as a supplementary strategy. All grey literature sources and dates of access must be documented.
The PRISMA flow diagram is a required figure in every PRISMA-compliant manuscript, documenting the fate of every record from initial identification through final inclusion. It must show: records identified (by source), duplicates removed, records screened and excluded at title/abstract stage, full texts assessed for eligibility, full texts excluded (with specific reasons for each), and studies included in the review. Inter-rater reliability at the screening stage is quantified as Cohen’s kappa — values above 0.6 are generally accepted as adequate; values above 0.8 indicate excellent agreement. We produce PRISMA 2020 flow diagrams in publication-ready format as a standard component of all meta-analysis deliverables.
Reference management: Covidence (developed by Cochrane) is the leading platform for managing the screening and data extraction workflow in systematic reviews, with built-in two-reviewer support and discrepancy tracking. Rayyan and DistillerSR are widely used alternatives. Standard reference managers (EndNote, Zotero, Mendeley) handle deduplication and reference organisation. Specify your required platform in your order brief and we calibrate our workflow accordingly.
Risk of Bias Assessment — The Correct Tool for Your Study Designs
Using the wrong risk of bias tool — or applying the right tool incorrectly — is a primary reason meta-analysis manuscripts are returned for major revision. The tool must match the study design. The assessment must be performed by two independent reviewers. Every domain judgment must be justified with reference to the source study.
RoB 2 — Revised Cochrane Tool for RCTs
The current Cochrane tool for assessing risk of bias in randomised controlled trials, replacing the original Cochrane RoB tool. A critical methodological improvement in RoB 2 is that assessment is performed at the outcome level, not the study level — recognising that a single RCT may have low risk of bias for its primary outcome but high risk for secondary outcomes due to selective reporting. Overall risk of bias judgment: Low, Some Concerns, or High. RoB 2 is mandatory for all Cochrane Reviews involving RCTs and expected by most health sciences journals.
ROBINS-I — Risk of Bias in Non-Randomised Studies of Interventions
The Cochrane tool for cohort studies, controlled before-after studies, interrupted time series, and other non-randomised intervention designs. ROBINS-I assesses bias across seven domains with risk judgments of Low, Moderate, Serious, Critical, or No Information. Appropriate for meta-analyses in health services research, public health, social policy, and economics where RCTs are not feasible or ethical. The confounding domain is often the most complex to assess — requiring identification of the critical confounders for the specific research question and judgment of whether they were controlled for adequately in the primary study.
QUADAS-2 — Quality Assessment of Diagnostic Accuracy Studies
The standard tool for systematic reviews of diagnostic test accuracy, assessing both risk of bias and applicability concerns. QUADAS-2 evaluates four domains for risk of bias (patient selection, index test, reference standard, flow and timing) and three domains for applicability concerns (patient selection, index test, reference standard). Required for all meta-analyses pooling sensitivity and specificity data, ROC curve analyses, and likelihood ratio estimates. Common in medical imaging, point-of-care testing, clinical decision aid evaluation, and nursing assessment meta-analyses. Responses: Low, High, or Unclear for each domain.
NOS, JBI Tools, and MMAT
The Newcastle-Ottawa Scale (NOS) is widely used for cohort and case-control studies in meta-analyses using a star-rating system (max 9 stars) across three domains: Selection, Comparability, and Outcome/Exposure. Widely published but methodologically less rigorous than ROBINS-I — many journals now prefer ROBINS-I for non-randomised studies. The Joanna Briggs Institute (JBI) Critical Appraisal Tools suite provides design-specific instruments for cross-sectional studies, case series, prevalence studies, and qualitative research. The Mixed Methods Appraisal Tool (MMAT) is used for reviews that include qualitative, quantitative, and mixed-methods primary studies in a single synthesis.
Sensitivity analysis for risk of bias: PRISMA 2020 and the Cochrane Handbook recommend a pre-specified sensitivity analysis that restricts the pooled estimate to studies with low or moderate risk of bias (excluding those with serious or critical risk). If the restricted pooled estimate differs substantially from the main analysis, the main result must be interpreted with explicit caution. We pre-specify and report this sensitivity analysis as a standard component of all meta-analysis deliverables. Our statistics and data analysis service handles all sensitivity and subgroup analysis components.
Statistical Methods — Effect Sizes, Pooling Models, and Heterogeneity
The statistical core of a meta-analysis involves three interrelated decisions: which effect size metric to use, which pooling model to apply, and how to quantify and investigate heterogeneity. Each decision must be pre-specified in the protocol and justified in the methods section — not selected post-hoc to produce a favourable result.
Effect Size Metrics
Cohen’s d & Hedges’ g
Standardised mean difference — used when studies measure the same continuous outcome using different instruments or scales. Cohen’s d divides the mean difference by the pooled SD. Hedges’ g applies a bias-correction for small samples (n < 20) and is preferred in psychology and education meta-analyses. Both express effect size in standard deviation units, enabling comparison across studies using different measurement tools.
Odds Ratio, Risk Ratio, Risk Difference
Used when the primary outcome is dichotomous (event vs no event: mortality, remission, relapse, adverse effect). The odds ratio (OR) is most common in case-control and logistic regression contexts. The risk ratio (RR) is more intuitively interpretable for prospective designs. The risk difference (RD) expresses absolute rather than relative effect and is essential for NNT calculation and clinical decision-making. Each can be converted to the others when event rates are known.
Pearson r (Fisher’s z)
Used in meta-analyses of correlational studies where the association between two continuous variables is the primary effect of interest. Because r is not normally distributed, it must be transformed to Fisher’s z before pooling and back-transformed for interpretation. Common in psychology, management, organisational behaviour, and education meta-analyses examining relationships between constructs. Hunter-Schmidt psychometric meta-analysis extends this to correct for measurement error and range restriction.
Heterogeneity Statistics — I², Q, and τ²
| Statistic | What It Measures | Interpretation Thresholds | Critical Limitation | Judgment |
|---|---|---|---|---|
| I² (I-squared) | Percentage of total variation across studies attributable to genuine heterogeneity rather than sampling error | 0–24%: Low; 25–49%: Moderate; 50–74%: High; ≥75%: Very high (Cochrane Handbook thresholds) | Increases with sample size even when between-study variance is constant. Does not reflect magnitude of heterogeneity — only proportion. Never use as sole decision criterion for whether to pool | Low <25% Mod 25–49% High 50–74% Very High ≥75% |
| Q (Cochran’s Q) | Chi-squared test of the null hypothesis that all studies share a common true effect. Tests for the presence of heterogeneity | p < 0.10 (not 0.05) is the conventional significance threshold due to low statistical power in meta-analyses with few studies | Low power when k is small (can miss real heterogeneity); very high power when k is large (flags clinically trivial heterogeneity). Must be interpreted alongside I² and τ² | Report Q statistic, degrees of freedom, and p-value. Neither alone is sufficient for heterogeneity judgment |
| τ² (tau-squared) | Estimated variance of the distribution of true effects across studies — the between-study variance on the effect size scale | Context-dependent: must be interpreted on the scale of the effect measure (e.g., τ = 0.3 on the log-OR scale represents substantial between-study variability in most clinical contexts) | Imprecisely estimated when k is small. The DerSimonian-Laird estimator systematically underestimates τ². REML and HKSJ provide more reliable estimates when k < 20. Report 95% CI for τ² | Report τ² (and √τ = τ) with 95% CI. Use REML estimator when k < 20. Compare across subgroups to identify moderators |
Investigating heterogeneity: When I² ≥ 50% or τ² is substantial, the sources of heterogeneity must be investigated using pre-specified methods. Subgroup analysis stratifies studies by a categorical moderator (study design, population age group, intervention intensity, comparator type) and compares pooled estimates across strata. Meta-regression models the effect size as a function of continuous or categorical moderator variables using weighted regression. Sensitivity analysis removes outlier studies, restricts to low-risk-of-bias studies, or varies model specification. All these analyses must be pre-specified in the protocol. Post-hoc data-dredging for significant subgroup effects is a serious methodological violation that reviewers are trained to identify and that should never be presented as confirmatory evidence.
Statistical Software for Meta-Analysis
The software platform you use must be named in your methods section. We work across all major platforms and deliver annotated, reproducible analysis scripts as a standard component of every statistical deliverable.
R — metafor & meta
The most powerful and flexible platform. metafor (Viechtbauer) provides comprehensive functions for all models, effect sizes, heterogeneity, meta-regression, and publication bias. meta (Schwarzer) offers a simpler interface. Open-source, reproducible, and preferred by methodological journals.
Primary RecommendationStata — metan / metareg
metan, metareg, metabias, and ipdmetan commands provide excellent meta-analysis capability with high-quality graphical output. Widely used in epidemiology, health economics, and clinical research. ipdmetan supports individual patient data meta-analysis.
Epidemiology StandardRevMan / RevMan Web
Cochrane’s dedicated review management software. Required for Cochrane Reviews. Manages the full workflow including RoB 2, data tables, forest plots, and GRADE SoF tables. RevMan Web is the current cloud-based version replacing RevMan 5.
Cochrane StandardCMA & SPSS
Comprehensive Meta-Analysis (CMA) offers a point-and-click interface for researchers who prefer not to code. Handles effect size conversion, all standard models, and publication bias assessment. SPSS meta-analysis macros supported for programmes requiring it.
Also SupportedReproducible scripts as standard: Every statistical analysis we perform is delivered with fully annotated, reproducible R or Stata scripts — every step explained in plain English so you can re-run the analysis, explain it to your committee, and modify it for sensitivity analyses without starting from scratch. This transparency is a requirement for publication and doctoral defence, and we deliver it as default. See our statistics and data analysis service.
Disciplines We Cover for Meta-Analysis Writing Help
Meta-analysis methodology has spread across virtually every research-active discipline. Each field has developed discipline-specific adaptations of the core methodology — and our writers understand those adaptations from the inside.
Clinical Medicine & Health Sciences
RCT meta-analyses, Cochrane Reviews, clinical guideline evidence synthesis. GRADE assessment, NNT calculation, ARR. Compliance with CONSORT, PRISMA, and specialty journal requirements for BMJ, JAMA, Lancet, and NEJM.
Psychology & Psychiatry
Treatment efficacy meta-analyses (CBT, DBT, pharmacotherapy), diagnostic accuracy reviews, prevalence meta-analyses. Hedges’ g as standard effect size. APA 7 format. Depression, anxiety, PTSD, OCD, and psychosis literature specifically covered.
Nursing & Allied Health
Evidence-based practice systematic reviews for DNP capstone and PhD dissertation requirements. JBI methodology. CINAHL, PubMed primary databases. Our nursing assignment help and DNP service cover meta-analysis components.
Education Research
Learning intervention meta-analyses, technology-enhanced learning, teacher development. Effect sizes for academic achievement outcomes. What Works Clearinghouse and Campbell Collaboration standards. Our education writing service.
Public Health & Epidemiology
Prevalence and incidence meta-analyses, risk factor aetiology reviews, population-level intervention evaluations. ROBINS-I for observational designs. DerSimonian-Laird and REML pooling of OR and RR from cohort and case-control studies.
Management & Organisational Behaviour
Leadership, motivation, job satisfaction, and HRM intervention meta-analyses. Hunter-Schmidt psychometric meta-analysis correcting for measurement error and range restriction. Common in Academy of Management, JAP, and SMJ submissions.
Economics & Social Policy
Programme evaluation, labour market intervention reviews, development economics evidence synthesis. Heterogeneous design pools requiring ROBINS-I. Regression discontinuity and DiD designs incorporated. Campbell Collaboration standards.
Environmental & Natural Sciences
Ecological meta-analyses of biodiversity, climate adaptation, and pollutant exposure. Hedges’ d as standard ecological effect size. ROSES reporting standard. Our environmental science service.
Criminology & Social Work
Offender rehabilitation programme evaluations, recidivism reduction reviews, social intervention effectiveness. Campbell Crime and Justice Group standards. Binary event rate meta-analysis for recidivism outcomes across jurisdictions.
Meta-Analysis Writing Help Pricing
Meta-analysis is among the most technically demanding academic writing services we offer. Every pricing tier includes an annotated analysis script, PRISMA-compliant writing, and one revision round as standard. No hidden charges.
Section or Chapter Support
- Introduction with rationale and PICO framework
- Methods section — PRISMA 2020-compliant structure
- Results section with heterogeneity interpretation
- Discussion, limitations, and GRADE narrative
- APA 7, Vancouver, or journal house style
- Turnitin originality report included
- One revision round included
Complete Meta-Analysis Manuscript
- Full PRISMA 2020-compliant manuscript
- PICO framework and PROSPERO protocol development
- Multi-database search strategy (PRESS format)
- PRISMA flow diagram — publication-ready vector
- Risk of bias assessment (RoB 2 / ROBINS-I / QUADAS-2)
- Forest plot(s) — main and subgroup analyses
- Heterogeneity: I², Q, τ² with 95% CI
- Publication bias: Egger’s test, funnel plot, trim-and-fill
- GRADE Summary of Findings table (GRADEpro GDT)
- Annotated R / Stata analysis script
- Turnitin report + one revision round
Add-On Components
Available as standalone or as additions to a main order.
PROSPERO protocol development and registration documentation
Multi-database search strategy with full PRESS documentation
Statistical analysis: effect sizes, pooling, heterogeneity, subgroup, publication bias (R or Stata with annotated script)
PRISMA flow diagram + characteristics of included studies table, publication-ready
GRADE Summary of Findings table using GRADEpro GDT with certainty assessment narrative
Rush delivery (48 hr) for individual text sections only — not available for full papers
First-time order? Apply your 15% new client discount at checkout. See the full pricing page. Our money-back guarantee applies to all orders.
How to Get Your Meta-Analysis Written
Submit Your Brief
Upload your PICO question, existing protocol or PROSPERO registration, included studies or search results, citation style, and deadline. Specify your required software platform (R, Stata, RevMan) and any supervisor guidelines or journal requirements. Precision here determines precision in the output.
Matched to a Specialist
Your order goes to a writer with domain expertise in your specific discipline and meta-analysis methodology — not a generalist. Health sciences orders go to writers who know RoB 2 and GRADE. Management orders go to writers familiar with Hunter-Schmidt and HKSJ. The matching is methodological, not just topical.
Analysis & Drafting
Statistical analysis is performed in R or Stata with annotated scripts. Forest plots, PRISMA flow diagrams, and GRADE SoF tables are produced in publication-ready format. Each manuscript section is written to PRISMA 2020 standards and your journal or institutional format. For dissertation orders, committee expectations are factored in at this stage.
Review & Revise
Evaluate the draft against your supervisor’s guidance, journal requirements, or dissertation rubric. One revision round is included — supervisor or reviewer feedback is treated as revision instructions. Request adjustments before final delivery. See our revision policy.
Download & Submit
Receive the final manuscript with Turnitin originality report, all figures in submission-ready format, and your annotated analysis script. For urgent section work, see our fast-turnaround service.
What Researchers Say
“My DNP capstone required a full systematic review and meta-analysis on nurse-led hypertension management interventions. I had the included studies identified and the data extracted, but the statistical analysis — calculating effect sizes, running the REML random-effects model, interpreting an I² of 68%, conducting the pre-specified subgroup analysis by intervention delivery format, producing the publication bias assessment — was completely beyond what my programme had trained me to do. The annotated R script I received was not only methodologically correct but explained in plain English at every step, so I could walk my committee through the analysis line by line. My chair commented that the heterogeneity analysis was ‘the most technically sophisticated section of any DNP capstone she had supervised this year.’ I passed my defence on the first attempt.”
“The PRISMA flow diagram and RoB 2 traffic light plot my writer produced were exactly to the journal’s formatting specifications. The GRADE SoF table — something I had been struggling to complete for weeks — was submitted with the manuscript on first submission to Systematic Reviews. Accepted with minor revisions. I could not have produced this level of methodological detail on my own timeline.”
“My supervisor rejected my search strategy twice — once for missing grey literature, once for the string not being reproducible. The strategy I received included full PRESS documentation, PubMed and Embase strings with MeSH terms, ClinicalTrials.gov and WHO ICTRP grey literature coverage, and a reference list hand-search protocol. My supervisor approved it without amendment and said it was ‘the standard she expected all doctoral students to meet from the start.'”
“I am a management PhD student using Hunter-Schmidt psychometric meta-analysis — a method most writing services have never heard of. The writer understood the distinction between bare-bones and full-distribution meta-analysis, applied the artifact distribution method correctly, and produced a moderator analysis section my committee found genuinely sophisticated. The correction for measurement error changed my pooled estimate substantially, and the discussion of that difference became the most theoretically interesting part of my paper.”
Frequently Asked Questions About Meta-Analysis Writing Help
What is a meta-analysis and how does it differ from a systematic review? +
A meta-analysis is a quantitative research synthesis method that statistically combines the effect estimates from multiple independent studies addressing the same research question. A systematic review is the broader process: a rigorous, pre-specified literature search, screening, and synthesis. All meta-analyses are systematic reviews — but not all systematic reviews include a meta-analysis. Statistical pooling (the meta-analysis) is only appropriate when included studies are sufficiently similar in design, population, intervention, and outcome. When pooling is not appropriate, the systematic review synthesises evidence narratively. These two terms are not interchangeable, and using them incorrectly in a manuscript signals methodological unfamiliarity to peer reviewers and dissertation committees.
Do I need to register my protocol on PROSPERO? +
If your review will be submitted to a peer-reviewed journal or is a doctoral dissertation following Cochrane, Campbell, or JBI standards, PROSPERO registration before the search begins is strongly recommended and increasingly required. It creates a public, date-stamped record of your pre-specified methods (PICO question, eligibility criteria, planned databases, statistical analysis plan), protecting against accusations of outcome-switching and selective reporting. Most journals require a PROSPERO number in the methods section. If you have already started searching without registering, you can still register retrospectively — but must disclose this in the manuscript. We assist with protocol development and PROSPERO registration documentation as part of our full meta-analysis service.
What statistical software do you use and will I receive the analysis script? +
We primarily use R (metafor and meta packages) and Stata (metan, metareg, metabias). We also work with RevMan for Cochrane-format reviews and Comprehensive Meta-Analysis (CMA). For every statistical deliverable, you receive a fully annotated, reproducible analysis script — every function explained in plain English so you can re-run the analysis, walk your committee through it, and modify it for sensitivity analyses. This transparency is a requirement for journal publication and doctoral defence, and we deliver it as standard, not as an add-on. Specify your required platform in your order brief. Our statistics and data analysis service covers all quantitative components.
My I² is 70%. Does that mean I cannot pool the studies? +
No — high I² does not automatically mean pooling is invalid. I² of 70% means that approximately 70% of total variation across studies reflects genuine between-study differences in true effects rather than sampling error. The pooled estimate under a random-effects model should be interpreted as an average of a distribution of effects, not a single common effect. High heterogeneity means you must investigate its sources (pre-specified subgroup analysis, meta-regression), report τ² alongside I² and Q, and interpret the pooled estimate cautiously. The GRADE framework will downgrade certainty of evidence for inconsistency when I² is substantial and unexplained. We assist with heterogeneity investigation including subgroup analyses, meta-regression, outlier diagnostics, and the discussion of what high heterogeneity means for the clinical or practical applicability of the findings. See our statistics service.
Can you help with a DNP capstone or nursing dissertation meta-analysis? +
Yes — nursing and allied health meta-analyses are among our most frequent orders. DNP capstone and PhD dissertation systematic reviews in nursing typically follow JBI or Cochrane methodology, use CINAHL, PubMed, and PsycINFO as primary databases, apply QUADAS-2 for diagnostic reviews or RoB 2 for intervention reviews, and present findings in APA 7 format. Our nursing assignment help, DNP assignment service, Walden nursing service, and Chamberlain nursing service all cover meta-analysis components as part of doctoral research support.
Can you help me respond to peer reviewer comments on a submitted meta-analysis? +
Yes — this is a frequently requested service. Peer reviewers of meta-analyses commonly request: additional sensitivity analyses (excluding high-risk-of-bias studies, removing outliers); additional subgroup analyses (which must be labelled as exploratory if not pre-specified); GRADE assessment if absent; clarification of model selection rationale; funnel plot or Egger’s test if k ≥ 10; or revisions to the search strategy documentation. We review the full reviewer report, produce a structured response-to-reviewers letter, and deliver revised manuscript sections addressing each comment. Contact us with the revision letter for a quote and turnaround estimate. See our editing and manuscript revision service.
How long does a full meta-analysis paper take to write? +
A full meta-analysis paper — including protocol, methods, PRISMA flow diagram, risk of bias assessment, statistical analysis, forest plot interpretation, GRADE SoF table, and complete manuscript — requires a minimum of five to seven days for standard orders. Statistical analysis scripts must be developed, tested, and annotated. Risk of bias assessments must be conducted study-by-study. The methods section must document every decision precisely enough for replication. Individual text sections (introduction, discussion) can be delivered in 72–96 hours. Rush delivery (48 hours) is available for individual sections only, with a +50% surcharge. We confirm the realistic turnaround for your specific deliverable when you submit your brief — not after payment. See our fast-turnaround service.
Is the service confidential? +
Every order is protected by a non-disclosure agreement. Your name, institution, programme, research question, and all manuscript content are never shared with any third party. We do not retain your completed work after delivery, add it to any database, or reuse it for another client. All data transmission is SSL-encrypted. Our full privacy policy and academic integrity statement are available on our website. See also our FAQ page for general service questions.
Other Research Support Services for Graduate Students
Dissertation & Thesis Writing
Full doctoral dissertation support including chapters, methodology, and final manuscript. Our dissertation service handles doctoral-level complexity.
Statistics & Data Analysis
Quantitative analysis in R, Stata, SPSS, and SAS. Meta-analytic statistics, regression, multilevel modelling. Our statistics service covers all methods.
Literature Review Writing
Narrative and systematic literature reviews without meta-analysis. Thematic synthesis and comprehensive evidence mapping. Our literature review service.
Research Paper Writing
Primary research, theoretical papers, and research reports across all disciplines. Our research paper service for full manuscript support.
Editing & Proofreading
Academic English editing, peer reviewer response letters, and manuscript revision for journal submission. Our editing service.
PhD Dissertation Services
Full doctoral dissertation support including proposal, prospectus, and individual chapters. Our PhD dissertation service.
The Cochrane Standard Is Not Optional.
It Is the Goal.
PRISMA 2020. RoB 2 risk of bias. REML random-effects pooling. GRADE certainty appraisal. Egger’s test. Annotated R scripts. This is what a publication-standard meta-analysis requires. It is exactly what we produce.
Get Meta-Analysis Writing HelpConfidential · PRISMA 2020 Compliant · Reproducible Scripts · Money-back guarantee